Back to Rankings

LNAI

Lunai BioworksF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
LNAI vs peer average
34/100
LNAI vs. peer average (F vs. D)
Grade spread
B 2 · D 5 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

NTLA is the first available peer comparator.

Larger gene-editing peer that rerates on clinical proof points.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerNTLAIntellia Therapeutics
LNAI
Lunai Bioworks
NTLA
Intellia Therapeutics
Grade
F
D
Momentum
8
17
Value
41
41
Sentiment
0
65
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs NTLA

LNAI / NTLA
Grade Position
Below peers
LNAI vs. peer average (F vs. D)
34/100
Momentum
8
NTLA
Value
41
LNAI
Sentiment
0
NTLA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs LNAI
1
NTLA
NTLA
D
40/100
-1
2
IBIO
IBIO
B
80/100
-3
3
INO
INO
D
40/100
-1
4
GDTC
CytoMed Therapeutics Ltd Common
D
40/100
-1
5
HOTH
Hoth Therapeutics Inc Common
F
20/100
Even
NTLA is the first peer returned for this comparison set.